ChampionX Declares Quarterly Dividend
THE WOODLANDS, Texas, May 16, 2024 (GLOBE NEWSWIRE) — ChampionX Corporation (Nasdaq: CHX) announced today its Board of Directors has […]
Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease
LEXINGTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic […]
OpGen Announced 1-for-10 Reverse Stock Split
ROCKVILLE, Md., May 16, 2024 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) today announced that the […]
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
– First patient dosed in trial to evaluate the safety, pharmacokinetics and pharmacodynamics of TOUR006 in patients with inflammatory risk […]
First Wave BioPharma Changes Name to Entero Therapeutics
Rebranding introduced as Company advances toward Phase 3 clinical trial with lead asset – latiglutenase for the treatment of celiac […]
Liquidity Services Announces Participation in Upcoming Investor Conferences
BETHESDA, Md., May 16, 2024 (GLOBE NEWSWIRE) — Liquidity Services (NASDAQ:LQDT), a leading global commerce company powering the circular economy, […]
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
– After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median progression-free survival (11.2 months), […]
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
NESS ZIONA, Israel, May 16, 2024 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients […]
Xunlei Announces Unaudited Financial Results for the First Quarter Ended March 31, 2024
SHENZHEN, China, May 16, 2024 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading technology company […]
JD.com Announces First Quarter 2024 Results
BEIJING, May 16, 2024 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter), […]
